November 1, 2023
Shionogi President and CEO Isao Teshirogi Shionogi enjoyed record earnings in the first half of FY2023, scoring all-time highs in both sales and profits chiefly buoyed by the COVID-19 pill Xocova (ensitrelvir), according to its financial report released on October...read more